Cargando…

Prognostic stromal gene signatures in breast cancer

INTRODUCTION: Global gene expression analysis of tumor samples has been a valuable tool to subgroup tumors and has the potential to be of prognostic and predictive value. However, tumors are heterogeneous, and homogenates will consist of several different cell types. This study was designed to obtai...

Descripción completa

Detalles Bibliográficos
Autores principales: Winslow, Sofia, Leandersson, Karin, Edsjö, Anders, Larsson, Christer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360948/
https://www.ncbi.nlm.nih.gov/pubmed/25848820
http://dx.doi.org/10.1186/s13058-015-0530-2
_version_ 1782361601597243392
author Winslow, Sofia
Leandersson, Karin
Edsjö, Anders
Larsson, Christer
author_facet Winslow, Sofia
Leandersson, Karin
Edsjö, Anders
Larsson, Christer
author_sort Winslow, Sofia
collection PubMed
description INTRODUCTION: Global gene expression analysis of tumor samples has been a valuable tool to subgroup tumors and has the potential to be of prognostic and predictive value. However, tumors are heterogeneous, and homogenates will consist of several different cell types. This study was designed to obtain more refined expression data representing different compartments of the tumor. METHODS: Formalin-fixed paraffin-embedded stroma-rich triple-negative breast cancer tumors were laser-microdissected, and RNA was extracted and processed to enable microarray hybridization. Genes enriched in stroma were identified and used to generate signatures by identifying correlating genes in publicly available data sets. The prognostic implications of the signature were analyzed. RESULTS: Comparison of the expression pattern from stromal and cancer cell compartments from three tumors revealed a number of genes that were essentially specifically expressed in the respective compartments. The stroma-specific genes indicated contribution from fibroblasts, endothelial cells, and immune/inflammatory cells. The gene set was expanded by identifying correlating mRNAs using breast cancer mRNA expression data from The Cancer Genome Atlas. By iterative analyses, 16 gene signatures of highly correlating genes were characterized. Based on the gene composition, they seem to represent different cell types. In multivariate Cox proportional hazard models, two immune/inflammatory signatures had opposing hazard ratios for breast cancer recurrence also after adjusting for clinicopathological variables and molecular subgroup. The signature associated with poor prognosis consisted mainly of C1Q genes and the one associated with good prognosis contained HLA genes. This association with prognosis was seen for other cancers as well as in other breast cancer data sets. CONCLUSIONS: Our data indicate that the molecular composition of the immune response in a tumor may be a powerful predictor of cancer prognosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-015-0530-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4360948
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43609482015-03-17 Prognostic stromal gene signatures in breast cancer Winslow, Sofia Leandersson, Karin Edsjö, Anders Larsson, Christer Breast Cancer Res Research Article INTRODUCTION: Global gene expression analysis of tumor samples has been a valuable tool to subgroup tumors and has the potential to be of prognostic and predictive value. However, tumors are heterogeneous, and homogenates will consist of several different cell types. This study was designed to obtain more refined expression data representing different compartments of the tumor. METHODS: Formalin-fixed paraffin-embedded stroma-rich triple-negative breast cancer tumors were laser-microdissected, and RNA was extracted and processed to enable microarray hybridization. Genes enriched in stroma were identified and used to generate signatures by identifying correlating genes in publicly available data sets. The prognostic implications of the signature were analyzed. RESULTS: Comparison of the expression pattern from stromal and cancer cell compartments from three tumors revealed a number of genes that were essentially specifically expressed in the respective compartments. The stroma-specific genes indicated contribution from fibroblasts, endothelial cells, and immune/inflammatory cells. The gene set was expanded by identifying correlating mRNAs using breast cancer mRNA expression data from The Cancer Genome Atlas. By iterative analyses, 16 gene signatures of highly correlating genes were characterized. Based on the gene composition, they seem to represent different cell types. In multivariate Cox proportional hazard models, two immune/inflammatory signatures had opposing hazard ratios for breast cancer recurrence also after adjusting for clinicopathological variables and molecular subgroup. The signature associated with poor prognosis consisted mainly of C1Q genes and the one associated with good prognosis contained HLA genes. This association with prognosis was seen for other cancers as well as in other breast cancer data sets. CONCLUSIONS: Our data indicate that the molecular composition of the immune response in a tumor may be a powerful predictor of cancer prognosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-015-0530-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-21 2015 /pmc/articles/PMC4360948/ /pubmed/25848820 http://dx.doi.org/10.1186/s13058-015-0530-2 Text en © Winslow et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Winslow, Sofia
Leandersson, Karin
Edsjö, Anders
Larsson, Christer
Prognostic stromal gene signatures in breast cancer
title Prognostic stromal gene signatures in breast cancer
title_full Prognostic stromal gene signatures in breast cancer
title_fullStr Prognostic stromal gene signatures in breast cancer
title_full_unstemmed Prognostic stromal gene signatures in breast cancer
title_short Prognostic stromal gene signatures in breast cancer
title_sort prognostic stromal gene signatures in breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360948/
https://www.ncbi.nlm.nih.gov/pubmed/25848820
http://dx.doi.org/10.1186/s13058-015-0530-2
work_keys_str_mv AT winslowsofia prognosticstromalgenesignaturesinbreastcancer
AT leanderssonkarin prognosticstromalgenesignaturesinbreastcancer
AT edsjoanders prognosticstromalgenesignaturesinbreastcancer
AT larssonchrister prognosticstromalgenesignaturesinbreastcancer